Advertisement
Canada markets close in 50 minutes
  • S&P/TSX

    22,147.29
    -199.47 (-0.89%)
     
  • S&P 500

    5,259.66
    -47.35 (-0.89%)
     
  • DOW

    39,062.60
    -608.44 (-1.53%)
     
  • CAD/USD

    0.7278
    -0.0027 (-0.37%)
     
  • CRUDE OIL

    76.91
    -0.66 (-0.85%)
     
  • Bitcoin CAD

    92,368.20
    -3,269.29 (-3.42%)
     
  • CMC Crypto 200

    1,458.83
    -43.83 (-2.92%)
     
  • GOLD FUTURES

    2,336.00
    -56.90 (-2.38%)
     
  • RUSSELL 2000

    2,041.23
    -40.48 (-1.94%)
     
  • 10-Yr Bond

    4.4750
    +0.0410 (+0.92%)
     
  • NASDAQ

    16,689.54
    -112.00 (-0.67%)
     
  • VOLATILITY

    13.29
    +1.00 (+8.14%)
     
  • FTSE

    8,339.23
    -31.10 (-0.37%)
     
  • NIKKEI 225

    39,103.22
    +486.12 (+1.26%)
     
  • CAD/EUR

    0.6733
    -0.0012 (-0.18%)
     

Elixxer Ltd. Announces Appointment of New Auditor

Montreal, Quebec--(Newsfile Corp. - April 17, 2023) - Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company") is pleased to announce that Kreston GTA LLP ("Kreston") has been retained by the Company to be its auditor. Kreston takes over from Baker Tilly WM LLP ("Baker"), who resigned as the Company's auditor on their own initiative, as announced on October 28, 2022. The resignation of Baker and the appointment of Kreston have been reviewed by the Company's audit committee and the board of directors as a whole. Baker previously confirmed that there are no reportable events, "disagreements" or "unresolved issues" (as those terms are defined in National Instrument 51-102 - Continuous Disclosure Obligations) in connection with the change of auditor.

About Elixxer Ltd.

Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSXV: ELXR) and the US OTC-Pink exchange (OTC Pink: ELIXF).

ADVERTISEMENT

For further information please contact:

Ferras Zalt, Chairman and Interim CEO: +44 20 7409 6680; ferras@elixxer.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward-Looking Statements

This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as "may", "will", "expect", "estimate", "anticipate", "intends", "believe" or "continue" or the negative thereof or similar variations. The actual results and performance of Elixxer could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under "Risk Factors and Risk Management" in Elixxer's most recent Management's Discussion and Analysis filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/162739